Log In
Print this Print this

DGAT1 inhibitors

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionSmall molecule enterocyte-directed diacylycerol O-acyltransferase-1 (DGAT1) inhibitors
Molecular Target Diacylglycerol O-acyltransferase-1 (DGAT1)
Mechanism of ActionDiacylglycerol O-acyltransferase-1 (DGAT1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDyslipidemia
Indication DetailsTreat dyslipidemia
Regulatory Designation
PartnerViking Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today